sglt2 vs glp 1 vs dpp4 Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting | Diabetes Therapy Expert Opinion: Optimum Clinical Approach

Microglial glucagon-like peptide-1 receptor (GLP-1R) activation can alleviate pain

Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels

Fatigue can emerge during GLP-1 receptor agonist therapy, but it's often manageable with the right dosing strategy

Variety and Flavor: Savor a delicious assortment of keto-friendly meals packed with flavor and nutrients

In this paper we will explore the current state of play, suggest a possible future path for global sugar consumption and highlight ways companies can adapt so they can benefit from GLP-1 receptor agonists disruption.